In one hospital system, with hs-cTn implementation, abnormal Tn levels (>99th percentile) increased from 15% to 47%.
With the approval of newer high-sensitivity cardiac troponin (hs-cTn) assays, there are questions about how that will change the frequency of abnormal findings and diagnoses. Investigators made use of the transition from 4th- to 5th-generation hs-cTn testing in several hospitals to assess changes in MI diagnoses.
The retrospective cohort study included 3536 unique patients (mean age, 62 years; 51% women) evaluated in the emergency department, half during the 6 months prior to implementation of the hs-cTn assay and half during the 6 months postimplementation.
The percentage of patients with at least one troponin measurement >99th percentile upper-reference-limit thresholds (10 ng/L for women, 15 ng/L for men) increased significantly after hs-c…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association